Now, everything is different. In August 2022, Dunham, 33, from St John's, Florida, started taking a compounded form of the buzzy weight loss drug semaglutide (marketed as Ozempic and Wegovy).

Semaglutide, one of several appetite suppressing drugs called GLP-1s, helped dampen her "food noise." Several of Dunham's family members are also on GLP-1s, and their Thanksgiving food bill is ...

At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...

Ashley Dunham's experience of the festive season changed after she started using a weight loss drug in 2022. Semaglutide, one of several appetite suppressing drugs called GLP-1s, helped dampen her ...

semaglutide, in a Phase 3 trial over 68 weeks, the Danish drugmaker said Friday. Citing data from its REDEFINE 1 trial, Novo Nordisk (NVO) added that the once-weekly injectable, comprising amylin ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...